PRESENTATION

Q2 FY2022 — Presentation

Q2 FY2022PDF · 18 pages726 KB
CACI Proprietary Information
CACI International Inc
Q2 FY22 Earnings Conference Call
January 27, 2022
CACI Proprietary Information

-- 1 of 18 --

2 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
There are statements made herein that do not address historical facts and, therefore, could be interpreted to be forward-
looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject
to risk factors that could cause actual results to be materially different from anticipated results. These risk factors include, but
are not limited to, the following: our reliance on U.S. government contracts, which includes general risk around the government
contract procurement process (such as bid protest, small business set asides, loss of work due to organizational conflicts of
interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in
U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget
priorities, such as for homeland security or to address global pandemics like COVID-19; legal, regulatory, and political change
from successive presidential administrations that could result in economic uncertainty; changes in U.S. federal agencies, current
agreements with other nations, foreign events, or any other events which may affect the global economy, including the impact
of global pandemics like COVID-19; the results of government audits and reviews conducted by the Defense Contract Audit
Agency, the Defense Contract Management Agency, or other governmental entities with cognizant oversight; competitive
factors such as pricing pressures and/or competition to hire and retain employees (particularly those with security clearances);
failure to achieve contract awards in connection with re-competes for present business and/or competition for new business;
regional and national economic conditions in the United States and globally, including but not limited to: terrorist activities or
war, changes in interest rates, currency fluctuations, significant fluctuations in the equity markets, and market speculation
regarding our continued independence; our ability to meet contractual performance obligations, including technologically
complex obligations dependent on factors not wholly within our control; limited access to certain facilities required for us to
perform our work, including during a global pandemic like COVID-19; changes in tax law, the interpretation of associated rules
and regulations, or any other events impacting our effective tax rate; changes in technology; the potential impact of the
announcement or consummation of a proposed transaction and our ability to successfully integrate the operations of our
recent and any future acquisitions; our ability to achieve the objectives of near term or long-term business plans; the effects of
health epidemics, pandemics and similar outbreaks may have material adverse effects on our business, financial position, results
of operations and/or cash flows; and other risks described in our Securities and Exchange Commission filings.
Forward-looking Statements

-- 2 of 18 --

3 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
On Today’s Call
John Mengucci
President and Chief
Executive Officer
Thomas Mutryn
Chief Financial Officer

-- 3 of 18 --

4 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Revenue +1.2% as reported, ~1% organic
Technology revenue +9%
Adjusted EBITDA Margin 10.6%1
Robust free cash flow of $117 million1
Strong contract awards of $2.0 billion; ~70% new business to CACI
Trailing twelve months (TTM) book-to-bill 1.6x
Q2 FY22 Performance
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.

-- 4 of 18 --

5 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Headwinds appeared during Q2
Increase in COVID cases limiting customer engagement and slowing some ramp-ups
Slowing pace of task orders, including some Technology
Supply chain challenges
Modestly reducing FY22 guidance to reflect headwinds continuing in 2H
Headwinds are short-term and not impacting customer demand or long-term
growth opportunities
Budget and Market Environment

-- 5 of 18 --

6 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Contract awards of $2.0 billion include nearly $600 million of unannounced
classified contracts
Cyber, Electromagnetic Spectrum, and Software-defined Technology
Enabled by both organic investments and M&A
Classified awards include a multi-hundred million sole-source renewal, new business wins,
and expansion of existing work
Continue to see good demand for network and digital application
modernization
Strong Awards

-- 6 of 18 --

7 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Continue to invest ahead of need and deploy capital to drive long-term
shareholder value
Acquired two Technology companies in Q2
SA Photonics
Photonics technologies for free space optical communications (“laser comms”)
Combination with CACI creates THE leading U.S.-based photonics provider
ID Technologies
Technology addressing NSA’s Commercial Solutions for Classified (CSfC), enabling
networking modernization and secure remote access
Complements CACI’s existing network modernization capabilities
Capital Deployment

-- 7 of 18 --

8 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Q2 Financial Summary
$4.18 $3.83
$0.00
$1.00
$2.00
$3.00
$4.00
$5.00
Q2 FY21 Q2 FY22
Diluted EPS (GAAP)
$1,469 $1,486
$1,200
$1,300
$1,400
$1,500
$1,600
Q2 FY21 Q2 FY22
Revenue (Ms)
Organic revenue growth of ~1%
Technology revenue +9%
Adjusted EBITDA Margin of 10.6%1
+1% -8%
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.
$4.69 $4.39
$0.00
$1.00
$2.00
$3.00
$4.00
$5.00
$6.00
Q2 FY21 Q2 FY22
Adjusted Diluted EPS1
-6%

-- 8 of 18 --

9 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Strong Cash Flow
$0
$50
$100
$150
$200
$250
$300
$350
$400
$450
$500
$550
$600
$650
$700
Cash Flow1 and CapEx
(millions, TTM)
Cash Flow from Operations excl. MARPA Capital Expenditures (CapEx)
1 Excludes CACI’s Master Accounts Receivable Purchase Agreement (MARPA). FY20 includes CARES Act payroll tax deferral
benefit of ~$41 million. FY21 includes CARES Act payroll tax deferral benefit of ~$53 million and tax payment of ~$90 million
due to certain tax elections. FY22E includes estimated tax benefits of ~$230 million and repayment of payroll tax deferral of
~$47 million. See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.
1
$0.00
$5.00
$10.00
$15.00
$20.00
$25.00
$30.00
$35.00
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22E
Free Cash Flow (FCF) per Share1
FY15 to FY20 FY16 to FY21 FY17 to FY22E
5-Year CAGR 	14.9% 	19.2% 	26.2%
FY22E is based on guidance provided on January 26, 2022. Investors are
reminded that actual results may differ from these estimates for reasons
described in the Company’s Safe Harbor Statement and filings with the SEC.

-- 9 of 18 --

10 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Acquired two Technology companies
Total consideration ~$500 million
FY22 expected revenue contribution ~$120 million
SA Photonics ~$25 million in revenue
IDT ~$95 million in revenue
Both businesses investing to support significant future growth
Investments expected to reduce FY22 Adjusted EBITDA margin by 10 basis points
Deploying Capital for Growth – Q2 Acquisitions

-- 10 of 18 --

11 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Updating FY22 Guidance
FY22 Guidance
Revenue
(millions) $6,300 – $6,400
Adjusted Net Income1
(millions) $430 – $440
Adjusted Diluted EPS1 $18.14 – $18.57
Free Cash Flow1
(millions) At least $720
(1) For additional information regarding non-GAAP measures, please see the related
explanation and reconciliation slides at the end of this presentation.
This guidance represents CACI views as of January 26, 2022. Investors are
reminded that actual results may differ from these estimates for reasons
described in the Company’s Safe Harbor Statement and filings with the SEC.
Organic revenue growth of
~2.5% at the midpoint, incl.
Afghanistan headwind (2%)
Adj. EBITDA Margin1 of ~10.7%
(incl. 10 bps impact from acquisitions)
Depreciation & amortization of
~$142 million
Diluted shares outstanding
expected to be ~23.7 million
Capital expenditures of
~$90 million

-- 11 of 18 --

12 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Positive Forward Indicators
93%
Existing Business
STRONG
Performance
4%
Recompetes
HIGH
Win Rate
3%
New Business
QUALITY
Pipeline
Strong Q2 FY22 contract awards of
$2.0 billion
TTM Book-to-Bill of 1.6x
Backlog of $24.1 billion, +8% YoY
Pipeline of submitted bids: $7.0 billion
~80% for new business to CACI
Bids expected to be submitted in the
next two quarters: $16.7 billion
>80% for new business to CACI

-- 12 of 18 --

13 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Delivering solid organic growth, healthy margins, and robust cash flow
Near-term headwinds do not change significant long-term growth opportunities
Investing ahead of customer need drives strong awards and growing backlog
CACI positioned to generate long-term growth, margin expansion,
free cash flow per share, and shareholder value
Our talented, innovative, diverse employees committed to success
Continuing to Execute

-- 13 of 18 --

14 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Adjusted net income and Adjusted diluted EPS are non-GAAP performance measures. We define Adjusted net income and Adjusted diluted EPS as GAAP net
income and GAAP diluted EPS, respectively, excluding intangible amortization expense and the related tax impact as we do not consider intangible amortization
expense to be indicative of our core operating performance. We believe that these performance measures provide management and investors with useful
information in assessing trends in our ongoing operating performance, provide greater visibility in understanding the long-term financial performance of the
Company, and allow investors to more easily compare our results to results of our peers. These non-GAAP measures should not be considered in isolation or as a
substitute for performance measures prepared in accordance with GAAP.
The Company views Adjusted EBITDA and Adjusted EBITDA margin, both of which are defined as non-GAAP measures, as important indicators of performance,
consistent with the manner in which management measures and forecasts the Company’s performance. Adjusted EBITDA is a commonly used non-GAAP
measure when comparing our results with those of other companies. We define Adjusted EBITDA as GAAP net income plus net interest expense, income taxes,
depreciation and amortization expense (including depreciation within direct costs), and earnout adjustments. We consider Adjusted EBITDA to be a useful metric
for management and investors to evaluate and compare the ongoing operating performance of our business on a consistent basis across reporting periods, as it
eliminates the effect of non-cash items such as depreciation of tangible assets, amortization of intangible assets primarily recognized in business combinations,
as well as the effect of earnout gains and losses, which we do not believe are indicative of our core operating performance. Adjusted EBITDA margin is adjusted
EBITDA divided by revenue. These non-GAAP measures should not be considered in isolation or as a substitute for performance measures prepared in
accordance with GAAP.
The Company defines Net cash provided by operating activities excluding MARPA, a non-GAAP measure, as net cash provided by operating activities calculated
in accordance with GAAP, adjusted to exclude cash flows from CACI’s Master Accounts Receivable Purchase Agreement (MARPA) for the sale of certain
designated eligible U.S. government receivables up to a maximum amount of $200.0 million. Free cash flow is a non-GAAP liquidity measure and may not be
comparable to similarly titled measures used by other companies. The Company defines Free cash flow as Net cash provided by operating activities excluding
MARPA, less payments for capital expenditures. Free cash flow per share is computed by dividing free cash flow, as defined here, by the diluted weighted average
number of common shares outstanding. The Company uses these non-GAAP measures to assess our ability to generate cash from our business operations and
plan for future operating and capital actions. We believe this measure allows investors to more easily compare current period results to prior period results and to
results of our peers. Free cash flow does not represent residual cash flows available for discretionary purposes and should not be used as a substitute for cash
flow measures prepared in accordance with GAAP.
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
Definitions of Non-GAAP Measures

-- 14 of 18 --

15 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Reconciliation of Net Income to Adjusted Net Income and
Diluted EPS to Adjusted Diluted EPS (Unaudited)
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
(in thousands, except per share data)
12/31/2021 12/31/2020 % Change 12/31/2021 12/31/2020 % Change
Net income, as reported 	90,299	$ 	106,478	$ 	-15.2% 178,408	$ 	200,122	$ 	-10.9%
Intangible amortization expense 	18,054 17,478 3.3% 	35,647 33,612 6.1%
Tax effect of intangible amortization1 (4,747) (4,595) 3.3% 	(9,373) (8,838) 6.1%
Adjusted net income 	103,606	$ 	119,361	$ 	-13.2% 204,682	$ 	224,896	$ 	-9.0%
12/31/2021 12/31/2020 % Change 12/31/2021 12/31/2020 % Change
Diluted EPS, as reported 	3.83	$ 	4.18	$ 	-8.4% 	7.52	$ 	7.86	$ 	-4.3%
Intangible amortization expense 	0.77 0.69 11.6% 	1.50 1.32 13.6%
Tax effect of intangible amortization1 (0.21) (0.18) 16.7% 	(0.39) (0.35) 11.4%
Adjusted diluted EPS 	4.39	$ 	4.69	$ 	-6.4% 	8.63	$ 	8.83	$ 	-2.3%
(in millions, except per share amounts)
Low End 	High End
Net income, as reported 	375	$ 	--- 	385	$
Intangible amortization expense 	74 --- 	74
Tax effect of intangible amortization1 	(20) --- 	(20)
Adjusted net income 	430	$ 	--- 	440	$
Low End 	High End
Diluted EPS, as reported 	15.83	$ 	--- 16.26	$
Intangible amortization expense 	3.13 --- 	3.13
Tax effect of intangible amortization1 	(0.82) --- (0.82)
Adjusted diluted EPS 	18.14	$ 	--- 18.57	$
(1) Calculation uses an assumed statutory tax rate of 26.3% on non-GAAP tax deductible adjustments.
Note: Numbers may not sum due to rounding.
FY22 Guidance Range
FY22 Guidance Range
Three Months Ended 	Six Months Ended
Three Months Ended 	Six Months Ended

-- 15 of 18 --

16 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Adjusted Earnings Before Interest, Taxes, Depreciation and
Amortization (Adjusted EBITDA) (Unaudited)
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
(in thousands) 	12/31/2021 12/31/2020 % Change 	12/31/2021 12/31/2020 % Change
Net income 	90,299	$ 	106,478	$ 	-15.2% 	178,408	$ 	200,122	$ 	-10.9%
Plus:
Income taxes 	22,799 	25,974 -12.2% 	51,321 	56,774 	-9.6%
Interest income and expense, net 	11,009 	9,087 	21.2% 	21,407 	19,067 	12.3%
Depreciation and amortization expense,
including amounts within direct costs 33,918 	33,041 	2.7% 	67,829 	64,053 	5.9%
Adjusted EBITDA 	158,025	$ 	174,580	$ 	-9.5% 	318,965	$ 	340,016	$ 	-6.2%
(in thousands) 	12/31/2021 12/31/2020 % Change 	12/31/2021 12/31/2020 % Change
Revenues, as reported 	1,485,778	$ 	1,468,711	$ 	1.2% 	2,976,676	$ 	2,928,217	$ 	1.7%
Adjusted EBITDA 	158,025 	174,580 	-9.5% 	318,965 	340,016 	-6.2%
Adjusted EBITDA margin 	10.6% 	11.9% 	10.7% 	11.6%
Three Months Ended 	Six Months Ended
Three Months Ended 	Six Months Ended

-- 16 of 18 --

17 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Reconciliation of Net Cash Provided by Operating Activities to Net
Cash Provided by Operating Activities Excluding MARPA and to Free
Cash Flow (Unaudited)
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
(in thousands) 	12/31/2021 12/31/2020 12/31/2021 12/31/2020
Net cash provided by operating activities 	122,812	$ 	205,387	$ 	308,765	$ 	382,287	$
Cash used in (provided by) MARPA 	6,038 (15,553) 	(5,451) 	242
Net cash provided by operating activities excluding MARPA 	128,850 189,834 	303,314 	382,529
Capital expenditures 	(11,429) (15,591) 	(21,632) 	(31,873)
Free cash flow 	117,421	$ 	174,243	$ 	281,682	$ 	350,656	$
(in millions) 	FY22 Guidance
Net cash provided by operating activities1 810	$
Cash used in (provided by) MARPA 	-
Net cash provided by operating activities excluding MARPA 	810
Capital expenditures 	(90)
Free cash flow 	720	$
Three Months Ended 	Six Months Ended
(1) Includes estimated tax benefits of $230 million related to certain tax elections, as well as payroll tax deferral repayment of
approximately $47 million.

-- 17 of 18 --

18 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call
Reconciliation of Net Cash Provided by Operating Activities to Net
Cash Provided by Operating Activities Excluding MARPA, to Free
Cash Flow, and to Free Cash Flow per share (Unaudited)
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
(in thousands, except per share data) 	6/30/2014 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 (E)
Net cash provided by operating activities 	203,470	$ 	226,862	$ 	242,577	$ 	281,250	$ 	321,460	$ 	555,297	$ 	518,705	$ 	592,215	$ 	810,000	$
Cash used in (provided by) MARPA 	- - - - - (192,527) (7,473) 17,973 -
Net cash provided by operating activities excluding MARPA 203,470 226,862 242,577 281,250 321,460 362,770 511,232 610,188 810,000
Capital expenditures 	(15,279) (17,444) (20,835) (43,268) (41,594) (47,902) (72,303) (73,129) (90,000)
Free cash flow 	188,191	$ 	209,418	$ 	221,742	$ 	237,982	$ 	279,866	$ 	314,868	$ 	438,929	$ 	537,059	$ 	720,000	$
Diluted weighted average shares outstanding 	25,155 24,388 24,802 25,069 25,255 25,395 25,485 24,992 23,700
Free cash flow per share 	7.48	$ 	8.59	$ 	8.94	$ 	9.49	$ 	11.08	$ 	12.40	$ 	17.22	$ 	21.49	$ 	30.38	$
5-Year CAGR 10.6% 14.9% 19.2% 26.2%
Note: 6/30/2022 (E) reflects estimate for fiscal year 2022 based on financial guidance provided.
Twelve Months Ended

-- 18 of 18 --